Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity

References

• Aditya NP, Chimote G, Gunalan K, et al. (2012). Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice. Exp Parasitol 131:292–9
   PubMed Web of Science ®Google Scholar
• Aditya NP, Patankar S, Madhusudhan B, et al. (2010). Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activity. Eur J Pharm Sci 40:448–55
   PubMed Web of Science ®Google Scholar
• Aditya NP, Shim M, Lee I, et al. (2013a). Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. J Agric Food Chem 61:1878–83
   PubMed Web of Science ®Google Scholar
• Aditya NP, Vathsala PG, Vieira V, et al. (2013b). Advances in nanomedicines for malaria treatment. Adv Colloid Interface Sci 201–202:1–17
   PubMed Web of Science ®Google Scholar
• Amin NC, Fabre H, Blanchin MD, et al. (2013). Determination of artemether and lumefantrine in anti-malarial fixed-dose combination tablets by microemulsion electrokinetic chromatography with short-end injection procedure. Malaria J 12:202
   PubMed Web of Science ®Google Scholar
• Date AA, Joshi MD, Patravale VB. (2007). Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 59:505–21
   PubMed Web of Science ®Google Scholar
• Egunsola O, Oshikoya KA. (2013). Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review. Malaria J 12:385
   PubMed Web of Science ®Google Scholar
• Joshi M, Pathak S, Sharma S, Patravale V. (2008). Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: nanoject. Int J Pharm 364:119–26
   PubMed Web of Science ®Google Scholar
• Joshi MD, Muller RH. (2009). Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 71:161–72
   PubMed Web of Science ®Google Scholar
• Madden TD, Bally MB, Hope MJ, et al. (1985). Protection of large unilamellar vesicles by trehalose during dehydration – retention of vesicle contents. Biochim Biophys Acta 817:67–74
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. (2001). Solid lipid nanoparticles – production, characterization and applications. Adv Drug Deliv Rev 47:165–96
   PubMed Web of Science ®Google Scholar
• Memvanga PB, Coco R, Préat V. (2013). An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with β-arteether. J Control Rel 172:904–13
   PubMed Web of Science ®Google Scholar
• Nandakumar DN, Nagaraj VA, Vathsala PG, et al. (2006). Curcumin-artemisinin combination therapy for malaria. Antimicrob Agents Chemother 50:1859–60
   PubMed Web of Science ®Google Scholar
• Nayak AP, Tiyaboonchai W, Patankar S, et al. (2010). Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B Biointerfaces 81:263–73
   PubMed Web of Science ®Google Scholar
• Parashar D, Kumar A, Aditya NP, Rayasa RM. (2013). Simultaneous estimation of artemether and lumefantrine in pharmaceutical dosage forms using derivative spectrophotometry. Asian J Res Chem 6:226–31
   Google Scholar
• Patil S, Suryavanshi S, Pathak S, et al. (2013). Evaluation of novel lipid based formulation of β-artemether and lumefantrine in murine malaria model. Int J Pharm 455:229–34
   PubMed Web of Science ®Google Scholar
• Peeters PAM, Deleest K, Eling WMC, Crommelin DJA. (1989a). Chloroquine blood-levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria. Pharm Res 6:787–93
   PubMed Web of Science ®Google Scholar
• Peeters, PAM, Huiskamp CWEM, Eling WMC, Crommelin DJA. (1989b). Chloroquine containing liposomes in the chemotherapy of murine malaria. Parasitology 98:381–6
   PubMed Web of Science ®Google Scholar
• Santos-Magalhães NS, Mosqueira VCF. (2010). Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev 62:560–75
   PubMed Web of Science ®Google Scholar
• Sosnik A, Amiji M. (2010). Nanotechnology solutions for infectious diseases in developing nations. Adv Drug Deliv Rev 62:375–7
   PubMed Web of Science ®Google Scholar
• Teng Z, Li Y, Luo Y, et al. (2013). Cationic Β-lactoglobulin nanoparticles as a bioavailability enhancer: protein characterization and particle formation. Biomacromolecules 14:2848–56
   PubMed Web of Science ®Google Scholar
• Van Vugt M, Looareesuwan S, Wilairatana P, et al. (2000). Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 94:545–8
   PubMed Web of Science ®Google Scholar
• Yeung S, Pongtavornpinyo W, Hastings IM, et al. (2004). Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg 71:179–86
   PubMed Web of Science ®Google Scholar